Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in...

Keywords

MedicineHazard ratioRelative riskVaccinationCohortAttendanceProportional hazards modelCoronavirus disease 2019 (COVID-19)DemographyDecilePediatricsInternal medicineImmunologyConfidence intervalDisease

Affiliated Institutions

Related Publications

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

Jamie Lopez Bernal , Nick Andrews , Charlotte Gower +16 more

Only modest differences in vaccine effectiveness were noted with the delta variant as compared with the alpha variant after the receipt of two vaccine doses. Absolute difference...

2021 New England Journal of Medicine 3040 citations

Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa

Raquel Viana , Sikhulile Moyo , Daniel G. Amoako +96 more

Abstract The SARS-CoV-2 epidemic in southern Africa has been characterized by three distinct waves. The first was associated with a mix of SARS-CoV-2 lineages, while the second ...

2022 Nature 1815 citations

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

Eric J. Haas , Frederick J. Angulo , John M. McLaughlin +12 more

Following the emergency use authorisation of the Pfizer-BioNTech mRNA COVID-19 vaccine BNT162b2 (international non-proprietary name tozinameran) in Israel, the Ministry of Healt...

2021 The Lancet 1722 citations

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity

Wilfredo F. García-Beltrán , Evan C. Lam , Kerri St. Denis +12 more

Vaccination elicits immune responses capable of potently neutralizing SARS-CoV-2. However, ongoing surveillance has revealed the emergence of variants harboring mutations in spi...

2021 Cell 1520 citations

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study

Jamie Lopez Bernal , Nick Andrews , Charlotte Gower +12 more

Abstract Objective To estimate the real world effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S vaccines against confirmed covid-19 symptoms (includ...

2021 BMJ 1367 citations

Publication Info

Year: 2022
Type: article
Citations: 1226
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1226

OpenAlex

Cite This

APA Style

                            
                                    Tommy Nyberg, 
                                
                                    Neil M. Ferguson, 
                                
                                    Sophie Nash
                                
                                et al.
                            
                            (2022). 
                            Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.. 
                            Bristol Research (University of Bristol)
                            
                            .
                            https://doi.org/10.17863/cam.81883

Identifiers

DOI: 10.17863/cam.81883